IIM
INTECH Investment Management Portfolio holdings
AUM
$10.7B
1-Year Return
23.47%
This Quarter Return
+4.48%
1 Year Return
+23.47%
3 Year Return
+97.82%
5 Year Return
–
10 Year Return
–
AUM
$10.3B
AUM Growth
+$1.38B
(+15%)
Cap. Flow
+$1.22B
Cap. Flow
% of AUM
11.8%
Top 10 Holdings %
Top 10 Hldgs %
25.81%
Holding
2,444
New
431
Increased
1,575
Reduced
361
Closed
67
Top Buys
| 1 |
Broadcom
AVGO
|
$49.6M |
| 2 |
Palantir
PLTR
|
$47.1M |
| 3 |
Merck
MRK
|
$46.5M |
| 4 |
Wells Fargo
WFC
|
$41M |
| 5 |
Centene
CNC
|
$40.7M |
Top Sells
| 1 |
Apple
AAPL
|
$116M |
| 2 |
Amazon
AMZN
|
$83.5M |
| 3 |
Vanguard Russell 2000 ETF
VTWO
|
$64.9M |
| 4 |
Deckers Outdoor
DECK
|
$47.3M |
| 5 |
Microsoft
MSFT
|
$43.7M |
Sector Composition
| 1 | Technology | 27.33% |
| 2 | Financials | 13.81% |
| 3 | Healthcare | 12.67% |
| 4 | Industrials | 10.74% |
| 5 | Consumer Discretionary | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2276
CS Disco
LAW
$355M
| $72.7K | ﹤0.01% |
+14,560
| New | +$72.7K |
|
2277
Cardlytics
CDLX
$48.5M
| $71.6K | ﹤0.01% |
19,310
+4,607
| +31% | +$17.1K |
|
|
NVRO
2278
DELISTED
NEVRO CORP.
NVRO
| $71.1K | ﹤0.01% |
19,121
+6,836
| +56% | +$25.4K |
|
2279
Biote Corp
BTMD
$109M
| $71.1K | ﹤0.01% |
+11,500
| New | +$71.1K |
|
2280
Entravision Communication
EVC
$227M
| $70.6K | ﹤0.01% |
+30,029
| New | +$70.6K |
|
2281
Fennec Pharmaceuticals
FENC
$251M
| $69.4K | ﹤0.01% |
+10,988
| New | +$69.4K |
|
2282
Ventyx Biosciences
VTYX
$170M
| $68.8K | ﹤0.01% |
31,411
+12,250
| +64% | +$26.8K |
|
2283
James River Group
JRVR
$247M
| $68.2K | ﹤0.01% |
+14,006
| New | +$68.2K |
|
|
INZY
2284
DELISTED
Inozyme Pharma
INZY
| $68.1K | ﹤0.01% |
+24,587
| New | +$68.1K |
|
2285
Evolution Petroleum
EPM
$177M
| $68.1K | ﹤0.01% |
+13,019
| New | +$68.1K |
|
2286
NN Inc
NNBR
$126M
| $67.9K | ﹤0.01% |
+20,752
| New | +$67.9K |
|
|
HSHP
2287
Himalaya Shipping
HSHP
$384M
| $67.6K | ﹤0.01% |
+13,906
| New | +$67.6K |
|
2288
Blink Charging
BLNK
$126M
| $67.5K | ﹤0.01% |
48,569
+18,110
| +59% | +$25.2K |
|
2289
Alector
ALEC
$279M
| $66.9K | ﹤0.01% |
35,382
+16,096
| +83% | +$30.4K |
|
2290
Dakota Gold
DC
$516M
| $66.8K | ﹤0.01% |
30,369
+20,270
| +201% | +$44.6K |
|
2291
Sutro Biopharma
STRO
$83.3M
| $66.5K | ﹤0.01% |
36,168
+9,832
| +37% | +$18.1K |
|
2292
Chegg
CHGG
$169M
| $66.3K | ﹤0.01% |
41,164
+9,514
| +30% | +$15.3K |
|
2293
Fate Therapeutics
FATE
$111M
| $65.1K | ﹤0.01% |
39,443
+8,497
| +27% | +$14K |
|
2294
Destination XL Group
DXLG
$67.9M
| $64.4K | ﹤0.01% |
23,922
+10,923
| +84% | +$29.4K |
|
2295
Rimini Street
RMNI
$425M
| $64K | ﹤0.01% |
+23,980
| New | +$64K |
|
|
KG
2296
Kestrel Group, Ltd.
KG
$199M
| $63.8K | ﹤0.01% |
+1,889
| New | +$63.8K |
|
2297
Clarus
CLAR
$150M
| $63.8K | ﹤0.01% |
+14,144
| New | +$63.8K |
|
2298
Nkarta
NKTX
$151M
| $63.5K | ﹤0.01% |
25,518
+9,244
| +57% | +$23K |
|
2299
Future Fuel
FF
$175M
| $63.4K | ﹤0.01% |
+11,985
| New | +$63.4K |
|
2300
Sight Sciences
SGHT
$193M
| $63.1K | ﹤0.01% |
+17,347
| New | +$63.1K |
|